ARCHIVES

Longterm Followup Finds Taxotere Improves Survival

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

May 30, 1980

FDA Publishes Parallel Track Rules, Accelerated Drug Approval Initiative

April 25, 1992

In Brief: Four More O.I. Awards Announced; Pediatric Clinical Trials RFP Canceled

September 6, 1985

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993

NCAB Accepts Plan for Organ Systems Program, Remains Split On Some Issues

February 11, 1983

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011